Lv1
44 积分 2022-07-21 加入
ESMO–ESTRO consensus statements on the safety of combining radiotherapy with immune checkpoint inhibitors, VEGF(R) inhibitors, or multitargeted tyrosine kinase inhibitors
27天前
已完结
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors
27天前
已完结
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
3个月前
已完结
Lymphoedema after head and neck cancer treatment: an overview for clinical practice
4个月前
已完结
Diagnostic Performance of Anti–Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma
5个月前
已关闭
Transcription of the epstein-barr virus genome in nasopharyngeal carcinoma
5个月前
已关闭
Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy
5个月前
已完结
Highs and Lows of Spatially Fractionated Radiation Therapy: Dosimetry and Clinical Outcomes
5个月前
已完结
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
5个月前
已完结
Aberrant lipid metabolism reshapes the immune landscape in bone metastasis of nasopharyngeal carcinoma
5个月前
已完结
皖公网安备34019202002308
